NCT04898374View on ClinicalTrials.gov

Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma

PHASE3RecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2026

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG

Gemcitabin/cisplatin

chemotherapy combination

Trial Locations (1)

11911

RECRUITING

Kuwait Cancer Control Center, Kuwait City

All Listed Sponsors

lead

Kuwait Cancer Control Center

OTHER

NCT04898374 - Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma | Biotech Hunter | Biotech Hunter